Hypopharyngeal cancer diagnostic study of choice

Jump to navigation Jump to search

Hypopharyngeal cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hypopharyngeal Cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiogram or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hypopharyngeal cancer diagnostic study of choice On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hypopharyngeal cancer diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hypopharyngeal cancer diagnostic study of choice

CDC on Hypopharyngeal cancer diagnostic study of choice

Hypopharyngeal cancer diagnostic study of choice in the news

Blogs on Hypopharyngeal cancer diagnostic study of choice

Directions to Hospitals Treating Hypopharyngeal cancer

Risk calculators and risk factors for Hypopharyngeal cancer diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Gertrude Djouka, M.D.[2]

Overview

The diagnostic study of choice for hypopharyngeal cancer is CT scan with contrast of head and neck. The definitive diagnosis of hypopharyngeal cancer is biopsy of the tumor.

Diagnostic Study of Choice


Staging

According to the American Joint Committee of Cancer (AJCC) TNM staging system, there are 5 stages of hypopharyngeal cancer based on the tumor size, lymph node involvement, and distant metastasis.

  • The following stages are used for hypopharyngeal cancer:[3]
AJCC

Stage

Stage

Grouping

Stage description
0 Tis

N0

M0

  • Tumor is only in the top layer of cells lining the inside of the hypopharynx and has not grown any deeper (Tis).
  • Cancer has not spread to nearby lymph nodes (N0) or to distant parts of the body (M0).
I T1

N0

M0

  • The tumor has grown deeper, but it is only in one part of the hypopharynx, and it is no more than 2 centimeters (cm) across (T1).
  • The cancer has not spread to nearby lymph nodes (N0) or to distant parts of the body (M0).
II T2

N0

M0

  • The tumor has grown into more than one part of the hypopharynx, OR it has grown into a nearby area, OR it is larger than 2 but no larger than 4 cm across and has not affected the vocal cords (T2).
  • Cancer has not spread to nearby lymph nodes (N0) or to distant parts of the body (M0).
III T3

N0

M0

OR

T1 to T3

N1

M0

  • The tumor is larger than 4 cm across, OR the tumor is affecting the movement of the vocal cords, OR the tumor has grown into the esophagus (T3).

Cancer has not spread to nearby lymph nodes (N0) or to distant parts of the body (M0).

OR

  • The tumor can be any size and might or might not have grown into structures outside the hypopharynx, and it might or might not have affected a vocal cord (T1 to T3).
  • Cancer has spread to a single lymph node on the same side of the neck as the tumor, which is no larger than 3 centimeters (cm) across (N1). Cancer has not spread to distant parts of the body (M0).
IVA T4a

N0 or N1

M0

OR

T1-T4a

N2

M0

  • The tumor has grown into the thyroid or cricoid cartilage, the hyoid bone, the thyroid gland, or nearby areas of muscle or fat. This is also known as moderately advanced local disease (T4a).
  • Cancer has not spread to nearby lymph nodes (N0), or it has spread to a single lymph node on the same side of the neck as the tumor, which is no larger than 3 centimeters (cm) across (N1). Cancer has not spread to distant parts of the body (M0).

OR

  • The tumor can be any size and might or might not have grown into structures outside the hypopharynx (as far as a moderately advanced disease), and it might or might not have affected a vocal cord (T1 to T4a). The cancer is N2:
    • It has spread to a single lymph node on the same side of the neck as the tumor, which is larger than 3 centimeters (cm) but no larger than 6 cm across, OR
    • It has spread to more than one lymph node on the same side of the neck as the tumor, none of which is larger than 6 cm across, OR
    • It has spread to at least one lymph node on the other side of the neck, none of which is larger than 6 cm across.
  • Cancer has not spread to distant parts of the body (M0).
IVB T4b

Any N

M0

OR

Any T

N3

M0

  • The tumor is growing into the area in front of the spine in the neck, surrounds a carotid artery, or is growing down into the space between the lungs. This is also known as very advanced local disease (T4b).
  • Cancer might or might not have spread to nearby lymph nodes (any N). It has not spread to distant parts of the body (M0).

OR

  • The tumor can be any size and might or might not have grown into structures outside the hypopharynx, and it might or might not have affected a vocal cord (any T).
  • Cancer has spread to at least one lymph node that is larger than 6 cm across, OR it has spread to a lymph node and then grown outside of the lymph node (N3). It has not spread to distant parts of the body (M0).
IVC Any T

Any N

M1

  • The tumor can be any size and might or might not have grown into structures outside the hypopharynx, and it might or might not have affected a vocal cord (any T).
  • Cancer might or might not have spread to nearby lymph nodes (any N). Cancer has spread to distant parts of the body (M1).

References

  1. Edge, Stephen (2010). AJCC cancer staging manual. New York: Springer. ISBN 978-0-387-88440-0.
  2. Helliwell TR (2003). "acp Best Practice No 169. Evidence based pathology: squamous carcinoma of the hypopharynx". J Clin Pathol. 56 (2): 81–5. PMC 1769882. PMID 12560383.
  3. "Hypopharyngeal Cancer Stages".